Home › Castration-Resistant Prostatic Cancer › Texas
Castration-Resistant Prostatic Cancer clinical trials in Texas
7 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in Texas.
Cities in Texas
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
- Michael E DeBakey VA Medical Center, Houston
- and 1 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT07164443A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Texas Oncology, Austin
- UT Southwestern Medical Center, Dallas
- Houston Metro Urology, Houston
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07225946A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Dallas-Fort Worth, Fort Worth
- NEXT Houston, Houston
- NEXT Oncology, San Antonio
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07719361Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 401, Houston
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05997615Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
- Houston Methodist Hospital, Houston
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449A Study of MGC026 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT06242470A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- NEXT Oncology, San Antonio
RecruitingPhase 1
Ages 18 and older · Men · Updated Aug 10, 2026 · NCT06067841From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.